NCT02188017View on ClinicalTrials.gov

Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)

PHASE4UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

September 30, 2017

Conditions
SarcoidosisPulmonary Sarcoidosis
Interventions
DRUG

Acthar gel

Given 80 units daily for 10 days, then randomized to receive either 40 or 80 units twice a week

Trial Locations (1)

45267

RECRUITING

University of Cincinnati, Cincinnati

Sponsors

Collaborators (1)

Mallinckrodt
All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

University of Cincinnati

OTHER

NCT02188017 - Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS) | Biotech Hunter | Biotech Hunter